What you should know about the new weight loss drug tirzepatide. Will it be affordable?
If an Eli Lilly weight-loss drug is approved, it could become the best-selling drug of all time, but concerns are growing over who will be able to afford it.Experts are confident that the drug, called tirzepatide, will receive approval from the Food and Drug Administration sometime next year. If that's the case, it would join two other popular, and expensive, recently approved weight-loss drugs on the market, Wegovy and Saxenda, both from drugmaker Novo Nordisk.Annual sales of tirzepatide could reach a record $48 billion, according to an estimate by Bank of America analyst Geoff Meacham. Another Wall Street analyst, UBS's…
